AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
BHP's annual results were reported to be largely consistent with forecasts, according to US bank Jefferies. The company's underlying profits (EBITDA) and net debt showed modest improvements, while the dividend payout aligned with expectations.
In other news, analysts from Peel Hunt have reviewed the latest developments from Faron Pharmaceuticals Limited (AIM), which recently received fast-track approval from the US Food and Drug Administration (FDA) for its lead candidate, bexmarilimab. Peel Hunt highlighted that the most recent data from the phase 2 trials revealed a 79% objective response rate (ORR) among 14 patients, a notable increase compared to the 0-20% ORR observed with existing treatments for this patient group.
On Tuesday morning, Associated British Foods PLC (LSE:ABF), the owner of Primark, experienced a decline following a downgrade by Deutsche Bank analysts. Deutsche Bank changed its rating from 'hold' to 'sell,' suggesting that the recovery in Primark's margins had been fully realized and predicting reduced profitability for the subsidiary British Sugar.
Helium One Global Ltd (LSE:HE1) is progressing towards commercial operations with recent developments, including a well test and an acquisition aimed at accelerating its path to generating revenue. Panmure Liberum praised the company’s $6.75 million acquisition of a 50% working interest in the Galactica Pegasus Helium Project in Colorado, which could begin production by mid-next year.
Shares in Shield Therapeutics PLC (LSE:STX) saw a 7% increase in early trading following the approval of its drug, Accrufer (ferric maltol), by Health Canada. This approval allows Shield's partner, Kye Pharmaceuticals, to introduce the drug to the Canadian market for treating iron deficiency anemia (IDA) in adults.
Additionally, supermarket suppliers Associated British Foods PLC and Bakkavor Group PLC (LSE) faced pressure in early trading after new data showed a reversal in UK shop prices for the first time in three years. The British Retail Consortium's figures for August indicated a 0.3% year-over-year decline in overall prices, impacting these companies' market performance.
